These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 27182510)

  • 1. TREATMENT OF BREAST CANCER: IMO STATE NIGERIA VERSUS INDIANA, USA WOMEN - COMPARATIVE ANALYTIC STUDY.
    Anele AA; Bowling M; Eckert GJ; Gonzalez E; Kipfer H; Sauder C
    J West Afr Coll Surg; 2014; 4(4):39-69. PubMed ID: 27182510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MISSILE AND BLAST INJURIES IN NIGERIA - THE SOUTHEAST EXPERIENCE.
    Chianakwana GU; Mbonu OO; Egwuonwu AO; Azike J; Eleweke N; Ekwunife C; Agu KA
    J West Afr Coll Surg; 2017; 7(4):18-33. PubMed ID: 30479989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knowledge and awareness of breast cancer among rural women in Umuowa Orlu Local Government Area Imo State, South East, Nigeria.
    Nwaneri A; Osuala EO; Okpala PU; Emesowum AC; Iheanacho P
    Niger J Clin Pract; 2017 Apr; 20(4):489-494. PubMed ID: 28406133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Visual Impairment and Blindness on Quality of Life of Patients in Owerri, Imo State, Nigeria.
    Ejiakor I; Achigbu E; Onyia O; Edema O; Florence UN
    Middle East Afr J Ophthalmol; 2019; 26(3):127-132. PubMed ID: 31619898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association Between Hospital Financial Distress and Immediate Breast Reconstruction Surgery After Mastectomy Among Women With Ductal Carcinoma In Situ.
    Richards CA; Rundle AG; Wright JD; Hershman DL
    JAMA Surg; 2018 Apr; 153(4):344-351. PubMed ID: 29214316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human immuno-deficiency virus antibody seroprevalence among pregnant women at booking at a university teaching hospital in South-Eastern Nigeria.
    Okeudo C; Ezem BU; Ojiyi EC
    Niger J Med; 2012; 21(2):227-30. PubMed ID: 23311197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The severity, outcome and challenges of breast cancer in Nigeria.
    Adesunkanmi AR; Lawal OO; Adelusola KA; Durosimi MA
    Breast; 2006 Jun; 15(3):399-409. PubMed ID: 16085418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Childhood burns in south eastern Nigeria.
    Okoro PE; Igwe PO; Ukachukwu AK
    Afr J Paediatr Surg; 2009; 6(1):24-7. PubMed ID: 19661661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Surgical treatment and prognosis of ductal carcinoma in situ: 526 cases analysis].
    Zhu SJ; Chen XS; Wu JY; Huang O; He JR; Zhu L; Chen WG; Li YF; Fei XC; Shen KW
    Zhonghua Wai Ke Za Zhi; 2017 Feb; 55(2):114-119. PubMed ID: 28162210
    [No Abstract]   [Full Text] [Related]  

  • 10. Association of Radiotherapy With Survival in Women Treated for Ductal Carcinoma In Situ With Lumpectomy or Mastectomy.
    Giannakeas V; Sopik V; Narod SA
    JAMA Netw Open; 2018 Aug; 1(4):e181100. PubMed ID: 30646103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Child survival and baseline surveys: a description of literacy rates of women of child bearing age in abia and imo States, Nigeria.
    Stephens TT; Oriuwa CL
    Int Q Community Health Educ; 1996 Jan; 16(1):79-90. PubMed ID: 20841038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malaria care-seeking behaviour among HIV-infected patients receiving antiretroviral treatment in South-Eastern Nigeria: A cross-sectional study.
    Chukwuocha UM; Iwuoha GN; Nwakwuo GC; Egbe PK; Ezeihekaibe CD; Ekiyor CP; Dozie INS; Burrowes S
    PLoS One; 2019; 14(5):e0213742. PubMed ID: 31071091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Referral Patterns and Treatment Type on Oncologic Outcomes for Women with Ductal Carcinoma In Situ.
    Wai ES; Lesperance M; Lu L; Alexander CS; Truong PT
    Cureus; 2017 Mar; 9(3):e1128. PubMed ID: 28465875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac risk indices of staff of Federal University Of Technology Owerri, Imo State, Nigeria.
    Emerole CO; Aguwa EN; Onwasigwe CN; Nwakoby BA
    Tanzan Health Res Bull; 2007 May; 9(2):132-5. PubMed ID: 17722417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The management of ductal carcinoma in situ (DCIS). The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Canadian Association of Radiation Oncologists.
    CMAJ; 1998 Feb; 158 Suppl 3():S27-34. PubMed ID: 9484276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iron status of some pregnant women in Orlu town--eastern Nigeria.
    Okwara JE; Nnabuo LC; Nwosu DC; Ahaneku JE; Anolue F; Okwara NA; Amah UK; Meludu SC; Dioka CE; Okwara EC; Egwurugwu JN; Ubajaka CF; Chukwulebe AE
    Niger J Med; 2013; 22(1):15-8. PubMed ID: 23441514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
    Di Saverio S; Catena F; Santini D; Ansaloni L; Fogacci T; Mignani S; Leone A; Gazzotti F; Gagliardi S; De Cataldis A; Taffurelli M
    Breast Cancer Res Treat; 2008 Jun; 109(3):405-16. PubMed ID: 17687650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What quality-of-life issues do women with ductal carcinoma in situ (DCIS) consider important when making treatment decisions?
    Mercieca-Bebber R; King MT; Boxer MM; Spillane A; Winters ZE; Butow PN; McPherson J; Rutherford C
    Breast Cancer; 2017 Sep; 24(5):720-729. PubMed ID: 28247220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trial.
    Polgár C; Ott OJ; Hildebrandt G; Kauer-Dorner D; Knauerhase H; Major T; Lyczek J; Guinot JL; Dunst J; Miguelez CG; Slampa P; Allgäuer M; Lössl K; Polat B; Kovács G; Fischedick AR; Fietkau R; Resch A; Kulik A; Arribas L; Niehoff P; Guedea F; Schlamann A; Pötter R; Gall C; Uter W; Strnad V;
    Lancet Oncol; 2017 Feb; 18(2):259-268. PubMed ID: 28094198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.